Role of high mobility group box 1 and its signaling pathways in renal diseases

Journal of Receptors and Signal Transduction

Volumn 34, Issue 5, 2014, Pages 348-350

  Zhou, Tian Biao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Acute kidney injury; Chronic kidney disease; Diabetic nephropathy; Granulomatous nephritis; High mobility group box 1; HMGB1; Signaling pathways

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; CYTOKINE;

ACUTE KIDNEY FAILURE; ANCA ASSOCIATED VASCULITIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; NEPHRITIS; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; KIDNEY;

ANIMALS; CYTOKINES; HMGB1 PROTEIN; HUMANS; KIDNEY; KIDNEY DISEASES; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 84907210826     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2014.904875     Document Type: Review

References (24)

1. Zhu P, Xie L, Ding HS, et al. High mobility group box 1 and kidney diseases (Review). Int J Mol Med 2013;31:763-8.
2. Qing X, Pitashny M, Thomas DB, et al. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett 2008;121:61-73.
3. Sato F, Maruyama S, Hayashi H, et al. High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin Pract 2008;108:c194-201.
4. Zakiyanov O, Kriha V, Vachek J, et al. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study. BMC Nephrol 2013;14:245.
5. Wang Q, Yao YM, Wang YB, et al. Effect of ethyl pyruvate on renal high mobility group box-1 protein expression and acute kidney injury in rats with delayed resuscitation after thermal injury. Zhonghua Wai Ke Za Zhi 2007;45:1210-3.
6. Wang Q, Yao YM, Wang WJ, et al. Effect of Xuebijing injection on renal high mobility group box-1 protein expression and acute kidney injury in rats after scald injury. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007;29:478-83.
7. Chung KY, Park JJ, Kim YS. The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate. Transplant Proc 2008;40:2136-8.
8. Li J, Gong Q, Zhong S, et al. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant 2011; 26:469-78.
9. Bruchfeld A, Qureshi AR, Lindholm B, et al. High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med 2008;14:109-15.
10. Zhu N, Yuan W, Zhou Y, et al. High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal dialysis patients. J Artif Organs 2011;14:125-32.
11. Nakamura T, Sato E, Fujiwara N, et al. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients. Metabolism 2009;58:1624-8.
12. Kim J, Sohn E, Kim CS, et al. The role of high-mobility group box-1 protein in the development of diabetic nephropathy. Am J Nephrol 2011;33:524-9.
13. Oyama Y, Hashiguchi T, Taniguchi N, et al. High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. Lab Invest 2010;90:853-66.
14. Bruchfeld A, Wendt M, Bratt J, et al. High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations. Mol Med 2011;17:29-35.
15. Wu H, Ma J, Wang P, et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010;21:1878-90.
16. Lynch J, Nolan S, Slattery C, et al. High-mobility group box protein 1: a novel mediator of inflammatory-induced renal epithelialmesenchymal transition. Am J Nephrol 2010;32:590-602.
17. Feng X, Hao J, Liu Q, et al. HMGB1 mediates IFN-gamma-induced cell proliferation in MMC cells through regulation of cyclin D1/CDK4/p16 pathway. J Cell Biochem 2012;113:2009-19.
18. Rabadi MM, Ghaly T, Goligorksy MS, et al. HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol 2012;303:F873-85.
19. Zhou TB, Qin YH, Li ZY, et al. All-trans retinoic acid treatment is associated with prohibitin expression in renal interstitial fibrosis rats. Int J Mol Sci 2012;13:2769-82.
20. Zhou TB. Signaling pathways of apoE and its role of gene expression in glomerulus diseases. J Recept Signal Transduct Res 2013;33:73-8.
21. Zhou TB, Qin YH. The potential mechanism for the different expressions of gelatinases induced by all-trans retinoic acid in different cells. J Recept Signal Transduct Res 2012;32:129-33.
22. Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases. J Recept Signal Transduct Res 2013;33:28-36.
23. Zhou TB. Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis. J Recept Signal Transduct Res 2012;32:298-303.
24. Zhou TB, Qin YH. The signaling pathways of LMX1B and its role in glomerulosclerosis. J Recept Signal Transduct Res 2012;32: 285-9.